Navigation Links
DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
Date:1/14/2008

Company Accelerating Efforts to Commercialize Bio-Based Technologies to

Meet Growing Global Demand

WILMINGTON, Del., Jan. 14 /PRNewswire-FirstCall/ -- DuPont (NYSE: DD) has named Nicholas C. Fanandakis group vice president - DuPont Applied BioSciences. In this newly created position, Fanandakis will lead the company's accelerated efforts to commercialize a range of bio-based products and technologies to meet growing global demand.

DuPont Applied BioSciences includes the following businesses: BioFuels, BioMaterials, BioSpecialties and BioMedical.

"Renewable energy, renewably sourced materials and other bio-based technologies are in high demand by the industries we serve," said Executive Vice President and Chief Innovation Officer Thomas M. Connelly, Jr. "DuPont is in a strong leadership position with a robust pipeline of product candidates, many of which are the result of the focused application of our scientific capabilities beginning more than a decade ago. With three decades of business leadership experience, Nick will lead our accelerated charge to deliver these products to the global marketplace."

Fanandakis, 51, currently vice president of planning, previously served four years as vice president and general manager of DuPont Chemical Solutions Enterprise. He has held a range of business leadership roles since joining the company in 1979.

William J. Harvey, 57, currently vice president - Corporate Operations, will succeed Fanandakis as vice president of planning.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

(Bios and photos of Nicholas Fanandakis and William Harvey are available at http://www2.dupont.com/Our_Company/en_US/executives/index.html )


'/>"/>
SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. DuPont Leaders Brief Investors on Agriculture Businesses
2. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
3. DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration
4. DuPont Named Among Top Biotechnology Employers by Science Magazine
5. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
6. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
7. DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest
8. KGI Names Kerry Howell Vice President for Advancement
9. Vical Names Andrew de Guttadauro Vice President, Corporate Development
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... MENLO PARK, Calif. , Feb. 4, 2016   ... a biopharmaceutical company focused on the development and commercialization of ... the 18 th Annual BIO CEO & Investor ... EST in New York, NY . ... provide an update on the ongoing clinical trial of ...
(Date:2/4/2016)... Md. , Feb. 4, 2016  Spherix Incorporated ... to the fostering and monetization of intellectual property, today ... and Uniden in the Northern District of ... moving forward.  Inter Partes Re-examination ... U.S. Patent Office.  The IPR was initiated on only ...
(Date:2/4/2016)... February 4, 2016 Strasbourg, France ... Inc. --> Strasbourg, France , to ... PharmaVentures is pleased to announce that it acted as ... manufacturing unit in Strasbourg, France , to ... --> --> Transgene (Euronext: TNG), a ...
(Date:2/3/2016)... 2016  Discovery Laboratories, Inc. (NASDAQ: DSCO ... KL4 surfactant therapies for respiratory diseases, today announced ... inducement award as a component of employment compensation ... President and Chief Executive Officer.  The award was ... 1, 2016 and granted as an inducement material ...
Breaking Biology Technology:
(Date:1/15/2016)... JUAN, Puerto Rico , Jan. 15, 2016 /PRNewswire/ ... companies big and small to find new ways to ... driven culture. iOS and Android ... device based on biometrics, transforming it into a hardware ... request that users swipe their fingerprint on their KodeKey ...
(Date:1/13/2016)... , January 13, 2016 /PRNewswire/ ... announced the addition of the  "India ... Estimation & Forecast (2015-2020)"  report ... http://www.researchandmarkets.com/research/7h6hnn/india_biometrics ) has announced the addition ... Identification Market - Estimation & Forecast ...
(Date:1/11/2016)... , Jan. 11, 2016  higi, the ... nearly 10,000 retail locations, web and mobile, today ... $40 million from existing investors. ... be devoted to further innovate higi,s health platform ... and web portal – including expanding services and ...
Breaking Biology News(10 mins):